193 related articles for article (PubMed ID: 18977350)
1. Toxoplasma gondii: a simple high-throughput assay for drug screening in vitro.
Jin C; Kaewintajuk K; Jiang J; Jeong W; Kamata M; Kim HS; Wataya Y; Park H
Exp Parasitol; 2009 Feb; 121(2):132-6. PubMed ID: 18977350
[TBL] [Abstract][Full Text] [Related]
2. Toxoplasma gondii: effects of Artemisia annua L. on susceptibility to infection in experimental models in vitro and in vivo.
de Oliveira TC; Silva DA; Rostkowska C; Béla SR; Ferro EA; Magalhães PM; Mineo JR
Exp Parasitol; 2009 Jul; 122(3):233-41. PubMed ID: 19389400
[TBL] [Abstract][Full Text] [Related]
3. Simple and efficient model systems of screening anti-Toxoplasma drugs in vitro.
Jin C; Jung SY; Kim SY; Song HO; Park H
Expert Opin Drug Discov; 2012 Mar; 7(3):195-205. PubMed ID: 22468951
[TBL] [Abstract][Full Text] [Related]
4. 6-trifluoromethyl-2-thiouracil possesses anti-Toxoplasma gondii effect in vitro and in vivo with low hepatotoxicity.
Choi HJ; Yu ST; Lee KI; Choi JK; Chang BY; Kim SY; Ko MH; Song HO; Park H
Exp Parasitol; 2014 Aug; 143():24-9. PubMed ID: 24830752
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative synergism of azasterols and antifolates against Toxoplasma gondii.
Dantas-Leite L; Urbina JA; de Souza W; Vommaro RC
Int J Antimicrob Agents; 2005 Feb; 25(2):130-5. PubMed ID: 15664482
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative activities of two novel quinuclidine inhibitors against Toxoplasma gondii tachyzoites in vitro.
Martins-Duarte ES; Urbina JA; de Souza W; Vommaro RC
J Antimicrob Chemother; 2006 Jul; 58(1):59-65. PubMed ID: 16702175
[TBL] [Abstract][Full Text] [Related]
7. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
[TBL] [Abstract][Full Text] [Related]
8. Effect of pyrimethamine and sulfadiazine on the fine structure and multiplication of Toxoplasma gondii in cell cultures.
Sheffield HG; Melton ML
J Parasitol; 1975 Aug; 61(4):704-12. PubMed ID: 1165554
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
Romand S; Pudney M; Derouin F
Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620
[TBL] [Abstract][Full Text] [Related]
10. Induction of sulfadiazine resistance in vitro in Toxoplasma gondii.
Doliwa C; Escotte-Binet S; Aubert D; Velard F; Schmid A; Geers R; Villena I
Exp Parasitol; 2013 Feb; 133(2):131-6. PubMed ID: 23206954
[TBL] [Abstract][Full Text] [Related]
11. Azithromycin and spiramycin induce anti-inflammatory response in human trophoblastic (BeWo) cells infected by Toxoplasma gondii but are able to control infection.
Franco PS; Gomes AO; Barbosa BF; Angeloni MB; Silva NM; Teixeira-Carvalho A; Martins-Filho OA; Silva DA; Mineo JR; Ferro EA
Placenta; 2011 Nov; 32(11):838-44. PubMed ID: 21908042
[TBL] [Abstract][Full Text] [Related]
12. Anti-toxoplasma activities of antiretroviral drugs and interactions with pyrimethamine and sulfadiazine in vitro.
Derouin F; Santillana-Hayat M
Antimicrob Agents Chemother; 2000 Sep; 44(9):2575-7. PubMed ID: 10952623
[TBL] [Abstract][Full Text] [Related]
13. In vitro effects of sulfadiazine and its metabolites alone and in combination with pyrimethamine on Toxoplasma gondii.
Schoondermark-van de Ven E; Vree T; Melchers W; Camps W; Galama J
Antimicrob Agents Chemother; 1995 Mar; 39(3):763-5. PubMed ID: 7793889
[TBL] [Abstract][Full Text] [Related]
14. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
Sanfelice RADS; da Silva SS; Bosqui LR; Machado LF; Miranda-Sapla MM; Panagio LA; Navarro IT; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
[TBL] [Abstract][Full Text] [Related]
15. [In vitro effect of (+)-usnic acid on Toxoplasma gondii tachyzoites].
Wei LL; Cheng YB; Si KW; Gu N; Li XQ; Li C; Yuan YK
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Dec; 26(6):438-41. PubMed ID: 19288918
[TBL] [Abstract][Full Text] [Related]
16. Using quantitative reverse transcriptase PCR and cell culture plaque assays to determine resistance of Toxoplasma gondii oocysts to chemical sanitizers.
Villegas EN; Augustine SA; Villegas LF; Ware MW; See MJ; Lindquist HD; Schaefer FW; Dubey JP
J Microbiol Methods; 2010 Jun; 81(3):219-25. PubMed ID: 20385175
[TBL] [Abstract][Full Text] [Related]
17. A new combined flow-cytometry-based assay reveals excellent activity against Toxoplasma gondii and low toxicity of new bisphosphonates in vitro and in vivo.
Shubar HM; Mayer JP; Hopfenmüller W; Liesenfeld O
J Antimicrob Chemother; 2008 May; 61(5):1110-9. PubMed ID: 18285314
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of new fluoroquinolones and evaluation of their in vitro activity on Toxoplasma gondii and Plasmodium spp.
Anquetin G; Rouquayrol M; Mahmoudi N; Santillana-Hayat M; Gozalbes R; Greiner J; Farhati K; Derouin F; Guedj R; Vierling P
Bioorg Med Chem Lett; 2004 Jun; 14(11):2773-6. PubMed ID: 15125930
[TBL] [Abstract][Full Text] [Related]
19. [In vitro measurement of the inhibitory effect of macrolides, lincosamides and synergestines on the growth of Toxoplasma gondii].
Derouin F; Nalpas J; Chastang C
Pathol Biol (Paris); 1988 Dec; 36(10):1204-10. PubMed ID: 3070460
[TBL] [Abstract][Full Text] [Related]
20. Screening for small molecule inhibitors of Toxoplasma gondii.
Kortagere S
Expert Opin Drug Discov; 2012 Dec; 7(12):1193-206. PubMed ID: 22998671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
